Double-Blind Randomised Investigation of Tibolone Alone or in Adjunct to Standard Antidepressant Treatment for Depression in Menopausal Women
Phase of Trial: Phase IV
Latest Information Update: 11 Aug 2017
At a glance
- Drugs Tibolone (Primary)
- Indications Depressive disorders; Menopausal syndrome
- Focus Therapeutic Use
- 07 Aug 2017 Planned End Date changed from 1 Jan 2017 to 1 Dec 2019.
- 07 Aug 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Dec 2019.
- 22 Jan 2016 Planned number of patients changed from 30 to 120 as per ClinicalTrials.gov record.